NEW YORK (
CHANGE IN RATINGS
was downgraded at Citigroup to sell from neutral. $12.50 price target. Challenges in its mainstay wireline access franchise, Citi said.
downgraded to hold at TheStreet Ratings.
downgraded to sell at TheStreet Ratings.
was downgraded at Keybanc from buy to hold. $45 price target. Management is taking multiple steps to improve shareholder value, Keybanc said.
was initiated with an outperform rating at Robert Baird. $119 price target. Truck orders should pick up in 2013, and new orders should help drive growth, Baird said.
Cabot Oil & Gas
was initiated with a neutral rating at UBS. $50 price target. Marcellus constraints won't be fixed until mid 2013, UBS said.
was initiated with a buy rating at UBS. $93 price target. Asset oiliness and well productivity are underappreciated, UBS said.
was downgraded at Jefferies to hold from buy. $47 price target. Finding it tougher to turn SSS trends, Jefferies said.
was initiated with a hold rating at Stifel Nicolaus. Company lacks near-term catalysts, Stifel Nicolaus said.
Kodiak Oil and Gas
was initiated with a buy rating at UBS. $12 price target. Expect higher capital efficiency in 2013 and upside to consensus production, UBS said.
was downgraded at Wunderlich from buy to hold. $110 price target. Company lost DIS studio content to NFLX, Wunderlich said.
was initiated with a market perform rating at FBR Capital Markets. $50 price target. Sales momentum has been decelerating at Victoria's Secret, FBR said.
was downgraded at Oppenheimer to perform from outperform. Hard to ignore PC outlook, Oppenheimer said.
was upgraded at UBS to buy from neutral. $39 price target. Risk/reward tilts favorably, UBS said.
was upgraded at Compass Point from neutral to buy. $63 price target. Stock is already pricing in lower net interest income, Compass Point said.
was initiated with a hold rating at Keybanc. Company is spending a lot and faces near-term rate decisions, Keybanc said.
was initiated with a buy rating at Needham. $15 price target. Company is a high-quality operator with high barriers to entry, Needham said.
was initiated with a buy rating at Lazard. $16 price target. New epilepsy drugs should drive growth, Lazard said.
was downgraded at Bank of America/Merrill Lynch from buy to neutral. $26 price target. Company is seeing lower results across the board, BofA/Merrill said.
was downgraded at William Blair to market perform from outperform. Valuation call and potential downward EPS revisions, Blair said. $65 price target.
was downgraded at FBR Capital Markets from outperform to market perform. $66 price target. Stock also cut from Top Picks list. Lower organic growth may cut into margins over the coming quarters, FBR Capital Markets said.
was initiated with a buy rating at Bank of America/Merrill Lynch. $18 price target. Company can grow twice as fast as its peers, BofA/Merrill said.
STOCK COMMENTS / EPS CHANGES
numbers lowered at Jefferies. Shares of ALTR now seen reaching $35, Jefferies said. Estimates also lowered on mid- quarter update. Hold rating.
numbers cut at UBS. Shares of DRI now seen reaching $52, UBS said. Estimates also lowered on negative F2Q preannouncement. Buy rating.
estimates reduced at Guggenheim through 2013, Guggenheim said. Company is seeing slower international demand. Neutral rating and $50 price target.
numbers raised at Citigroup. Shares of EW now seen reaching $98, Citigroup said. Estimates also increased on greater US TAVI revenues. Neutral rating.
estimates lowered at JP Morgan through 2013, JP Morgan said. Company is leveraged to slower international growth. Neutral rating and $43 price target.
numbers cut at Keybanc. MFRM estimates were reduced through 2013, Keybanc said. Company is facing increased competition. Buy rating and new $34 price target.
estimates, target cut at MKM. Shares of MSFT now seen reaching $28, according to MKM Partners. Estimates also reduced, as recent checks show lower demand for Windows 8 Surface.
numbers reduced at JMP. MTN estimates were cut through 2013, JMP Securities said. Company has had a slow start to its season. Outperform rating and new $60 price target.
numbers boosted at JMP. Shares of RBC now seen reaching $78, according to JMP Securities. Estimates also upped, as new products should help drive growth over the coming quarters. Outperform rating.
estimates trimmed at Citigroup through 2013, Citigroup said. Accelerated network investments. $39 price target and Buy rating.
numbers lowered at Jefferies. Shares of TIBX now seen reaching $25, Jefferies said. Estimates also lowered on weakness throughout BI/data analytics. Buy rating.
>To submit a news tip, email:
READERS ALSO LIKE:
and become a fan on
This article was written by a staff member of TheStreet.